Previous Page  17 / 65 Next Page
Information
Show Menu
Previous Page 17 / 65 Next Page
Page Background

Page 37

May 24-25, 2018

London, UK

Vascular Surgery 2018

3

rd

Edition of World Congress & Exhibition on

Vascular Surgery

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

Background:

The pathogenesis of abdominal aortic aneurysm

(AAA) involves a central component of chronic inflammation

which is predominantly mediated by myeloid cells. Both,

neutrophils and monocytes are recruited to the AAA wall and

intraluminal thrombus and contribute to vessel destruction by

the release of proteases and reactive oxygen species.

Purpose:

We hypothesized that the local activation of myeloid

cells may be reflected in systemic alterations of neutrophil

and monocyte populations as well as in associated soluble

factors which might serve as biomarkers to diagnose the often-

asymptomatic disease.

Methods:

The methods of this study were to establish their

diagnostic marker potential, neutrophil and monocyte subsets

were measured by flow cytometry in peripheral blood samples of

41 AAA patients and 38 healthy controls matched for age, sex,

body mass index and smoking habit. Comparably, circulating

factors relating to myeloid cell activation and recruitment were

assayed in plasma by multicytokine array and ELISA.

Results:

Significantly elevated levels of CD16+ monocytes,

activated neutrophils and newly released neutrophils were

recorded for AAA patients compared to controls. In line, the

monocyte chemoattractant protein 1 and myeloperoxidase

were significantly increased in patients´ plasma. The diagnostic

value was highest for myeloperoxidase, a mediator which is

released by activated neutrophils as well as CD16+ monocytes.

Comparison of the investigated myeloid factors with established

AAA parameters by multivariable logistic regression identified

myeloperoxidase and D-dimer as highly significant, independent

variables. These two biomarkers were combined to yield a

potent diagnostic score which was subsequently confirmed in

a validation cohort.

Conclusions:

Based on a comprehensive comparison of

myeloid cell activation parameters, plasma myeloperoxidase

was identified as the most potent AAA biomarker. Since D-dimer

and myeloperoxidase represent two sensitive markers of AAA

which reflect distinct components of the AAA pathomechanism

(thrombus formation and inflammation) they may be combined

to yield an improved diagnostic score.

Recent Publications

1. Takagi H, Manabe H, Kawai N, et al. (2009) Plasma

fibrinogen and D-dimer concentrations are associated

with the presence of abdominal aortic aneurysm: a

systematic review and meta-analysis. European Journal

of Vascular and Endovascular Surgery 38:273-277.

2. Sidloff D A, Stather P W, Choke E, et al. (2014) A

systematic review and meta-analysis of the association

between markers of hemostasis and abdominal aortic

aneurysm presence and size. Journal of Vascular

Surgery 59:528-535.

3. Golledge J, Muller R, Clancy P, et al. (2011) Evaluation of

the diagnostic and prognostic value of plasma D-dimer

for abdominal aortic aneurysm. European Heart Journal

32:354-364.

4. Houard X, Touat Z, Ollivier V, et al. (2009) Mediators

of neutrophil recruitment in human abdominal aortic

aneurysms. Cardiovascular Research 82:532-541.

5. Dale Ma, Ruhlman M K and Baxter B T (2015)

Inflammatory Cell Phenotypes in AAAs. Arteriosclerosis,

Thrombosis, and Vascular Biology 35:1746-1755

Biography

Branislav Zagrapan is pursuing his PhD on the topic of molecular and cellular

diagnostic and prognostic markers of abdominal aortic aneurysms. He is a

Pathologist in training at the Academic Teaching Hospital Feldkirch, Austria

branislav.zagrapan@meduniwien.ac.at

An improved diagnostic score for abdominal aortic aneurysms

based on a comprehensive analysis of myeloid cell parameters

Branislav Zagrapan, Christoph Neumayer, Wolf Eilenberg, Katharina Muench,

Renata Rajic, Patrick Kirchweger, Bernd Jilma, Christoph Domenig, Ihor Huk,

Georg Heinze

and

Christine Brostjan

Medical University of Vienna, Austria

Branislav Zagrapan et al., J Vasc Endovasc Therapy 2018, Volume 3

DOI: 10.21767/2573-4482-C1-002